Latest Protein families Stories
LONDON and BOSTON, January 23, 2015 /PRNewswire/ -- Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted
Olfactory Biosciences is just in time to deliver affordable non-prescription natural medicines that are topically applied, so that the consumer can have self-help for most common conditions.
The study, led by Martina Gentzsch, PhD, provides evidence that could help drug developers improve compounds aimed at correcting CFTR proteins in cystic fibrosis patients.
MENLO PARK, Calif., July 16, 2014 /PRNewswire/ -- Virobay, Inc., a clinical stage pharmaceutical company with a platform of cathepsin protease inhibitors being developed for the treatment
LONDON and BOSTON, July 7, 2014 /PRNewswire/ -- Heptares has solved structures across all major GPCR families (A, B and C) providing platforms for wide-ranging
For decades, experts have claimed that people were capable of detecting 10,000 different odors, but new research appearing in March 21 edition of Science suggests that the actual number of scents detectable by the human nose is considerably higher.
A new drug designed to stop a heart attack in its tracks, while reducing the damage caused, all without side effects, is one step closer to development thanks to a group of Melbourne scientists from Monash University.
Researchers at The Scripps Research Institute (TSRI) and Vanderbilt University have created the most detailed 3-D picture yet of a membrane protein that is linked to learning, memory, anxiety, pain and brain disorders such as schizophrenia, Parkinson's, Alzheimer's and autism.
While scientists know that a superfamily of genes inside olfactory receptors is responsible for our sense of smell – we still don’t know the mechanism behind the interpretation of odor molecules into a particular smell.
Researchers have used one of the brightest X-ray sources in the world to map the three-dimensional structure of an important cellular gatekeeper known as a G protein-coupled receptor, or GPCR.